Entheon Biomedical Corp. operates as a biotechnology research and development company. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2018-05-03. The firm is interested in treating addiction and substance-use disorders.
How did ENTBF's recent EPS compare to expectations?
The most recent EPS for Entheon Biomedical Corp is $, expectations of $.
How did Entheon Biomedical Corp ENTBF's revenue perform in the last quarter?
Entheon Biomedical Corp revenue for the last quarter is $
What is the revenue estimate for Entheon Biomedical Corp?
According to of Wall street analyst, the revenue estimate of Entheon Biomedical Corp range from $ to $
What's the earning quality score for Entheon Biomedical Corp?
Entheon Biomedical Corp has a earning quality score of /. The score is based on a four dimension of Profitability, Growth, Cash generation & Capital Allocation, and Leverage.
When does Entheon Biomedical Corp report earnings?
Entheon Biomedical Corp next earnings report is expected in
What are Entheon Biomedical Corp's expected earnings?
Entheon Biomedical Corp expected earnings is $, according to wall-street analysts.
Did Entheon Biomedical Corp beat earnings expectations?
Entheon Biomedical Corp recent earnings of $ expectations.